Diagnosis of a glioma has traditionally been used as a diagnostic criterion for NF2; however, on clinicopathologic review nearly 80% of lesions characterized as NF2-associated gliomas are found to be spinal intramedullary or cauda equina ependymomas. This evidence concerns the gene NF2 and central nervous system cancer.